These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 18558668)

  • 21. Design of multi-binding-site inhibitors, ligand efficiency, and consensus screening of avian influenza H5N1 wild-type neuraminidase and of the oseltamivir-resistant H274Y variant.
    García-Sosa AT; Sild S; Maran U
    J Chem Inf Model; 2008 Oct; 48(10):2074-80. PubMed ID: 18847186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel small-molecule inhibitor of the avian influenza H5N1 virus determined through computational screening against the neuraminidase.
    An J; Lee DC; Law AH; Yang CL; Poon LL; Lau AS; Jones SJ
    J Med Chem; 2009 May; 52(9):2667-72. PubMed ID: 19419201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rational development of neuraminidase inhibitor as novel anti-flu drug.
    Chintakrindi A; D'souza C; Kanyalkar M
    Mini Rev Med Chem; 2012 Oct; 12(12):1273-81. PubMed ID: 22512586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent advances in neuraminidase inhibitor development as anti-influenza drugs.
    Feng E; Ye D; Li J; Zhang D; Wang J; Zhao F; Hilgenfeld R; Zheng M; Jiang H; Liu H
    ChemMedChem; 2012 Sep; 7(9):1527-36. PubMed ID: 22807317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis and biological evaluation of sulfamethazine derivatives as potent neuraminidase inhibitors.
    Cheng LP; Zhang XY; Pang W; Xiao XZ
    Future Med Chem; 2024; 16(12):1205-1218. PubMed ID: 38989986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drugs against avian influenza a virus: design of novel sulfonate inhibitors of neuraminidase N1.
    Udommaneethanakit T; Rungrotmongkol T; Frecer V; Seneci P; Miertus S; Bren U
    Curr Pharm Des; 2014; 20(21):3478-87. PubMed ID: 24001233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of C-1 modified oseltamivir derivatives as potent influenza neuraminidase inhibitors.
    Ju H; Zhang J; Sun Z; Huang Z; Qi W; Huang B; Zhan P; Liu X
    Eur J Med Chem; 2018 Feb; 146():220-231. PubMed ID: 29407952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Computational Model for Docking of Noncompetitive Neuraminidase Inhibitors and Probing their Binding Interactions with Neuraminidase of Influenza Virus H5N1.
    Chintakrindi AS; Martis EA; Gohil DJ; Kothari ST; Chowdhary AS; Coutinho EC; Kanyalkar MA
    Curr Comput Aided Drug Des; 2016; 12(4):272-281. PubMed ID: 27412704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sensitivity of molecular docking to induced fit effects in influenza virus neuraminidase.
    Birch L; Murray CW; Hartshorn MJ; Tickle IJ; Verdonk ML
    J Comput Aided Mol Des; 2002 Dec; 16(12):855-69. PubMed ID: 12825619
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Profiling and characterization of influenza virus N1 strains potentially resistant to multiple neuraminidase inhibitors.
    Baek YH; Song MS; Lee EY; Kim YI; Kim EH; Park SJ; Park KJ; Kwon HI; Pascua PN; Lim GJ; Kim S; Yoon SW; Kim MH; Webby RJ; Choi YK
    J Virol; 2015 Jan; 89(1):287-99. PubMed ID: 25320319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and biological evaluation of NH
    Wang K; Yang F; Wang L; Liu K; Sun L; Lin B; Hu Y; Wang B; Cheng M; Tian Y
    Eur J Med Chem; 2017 Dec; 141():648-656. PubMed ID: 29107426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of a non-zwitterionic oseltamivir analogue as a potent influenza a neuraminidase inhibitor.
    Zhang H; Wang K; Zhu H; Zhao X; Zhao H; Lei Z; Chen B; Yang F; Liu K; Zhang K; Wang J; Tian Y
    Eur J Med Chem; 2020 Aug; 200():112423. PubMed ID: 32512482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis and biological evaluation of oseltamivir derivatives containing pyridyl group as potent inhibitors of neuraminidase for influenza A.
    Wang K; Lei Z; Zhao L; Chen B; Yang F; Liu K; Zhu H; Zhao H; Cao R; Zhang K; Tian Y
    Eur J Med Chem; 2020 Jan; 185():111841. PubMed ID: 31708183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacophore model of influenza neuraminidase inhibitors--a systematic review.
    Gong JZ; Liu Y; Xu WF
    Pharmazie; 2009 Oct; 64(10):627-32. PubMed ID: 19947162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuraminidase inhibitor R-125489--a promising drug for treating influenza virus: steered molecular dynamics approach.
    Mai BK; Li MS
    Biochem Biophys Res Commun; 2011 Jul; 410(3):688-91. PubMed ID: 21693105
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Computational design of novel, high-affinity neuraminidase inhibitors for H5N1 avian influenza virus.
    Park JW; Jo WH
    Eur J Med Chem; 2010 Feb; 45(2):536-41. PubMed ID: 19914748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Binding pattern of the long acting neuraminidase inhibitor laninamivir towards influenza A subtypes H5N1 and pandemic H1N1.
    Meeprasert A; Khuntawee W; Kamlungsua K; Nunthaboot N; Rungrotmongkol T; Hannongbua S
    J Mol Graph Model; 2012 Sep; 38():148-54. PubMed ID: 23079644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent progress and challenges in the discovery of new neuraminidase inhibitors.
    Chamni S; De-Eknamkul W
    Expert Opin Ther Pat; 2013 Apr; 23(4):409-23. PubMed ID: 23369206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human-like receptor specificity does not affect the neuraminidase-inhibitor susceptibility of H5N1 influenza viruses.
    Ilyushina NA; Govorkova EA; Gray TE; Bovin NV; Webster RG
    PLoS Pathog; 2008 Apr; 4(4):e1000043. PubMed ID: 18404209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Study of drug resistance of chicken influenza A virus (H5N1) from homology-modeled 3D structures of neuraminidases.
    Wang SQ; Du QS; Chou KC
    Biochem Biophys Res Commun; 2007 Mar; 354(3):634-40. PubMed ID: 17266937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.